Mounjaro pen sizes: the six UK strengths and what each one does

How the licensed pen ladder was built from clinical evidence

The six-strength schedule is not arbitrary. Eli Lilly designed the titration pathway to mirror what the SURMOUNT trial programme showed: the body tolerates tirzepatide better when the dose rises gradually, and the appetite-reducing effect deepens as the dose increases. The SURMOUNT-1 study, published in the New England Journal of Medicine, randomised 2,539 adults across 5 mg, 10 mg and 15 mg maintenance doses against placebo over 72 weeks. The 15 mg group achieved the largest average weight reduction, around 20–21% of starting body weight. That result underpins why the licensed schedule climbs steadily through the tirzepatide pen sizes available across the range rather than offering a single fixed dose.

The 2.5 mg pen has one job: adjustment. It carries no expectation of measurable weight loss on its own. Your system is getting used to a dual GIP and GLP-1 receptor agonist for the first time, and the nausea or digestive discomfort that many people notice in those first weeks is usually milder at this lower level. From there, a prescriber typically reviews progress at roughly four-week intervals before considering whether to move to the next pen up.

The NHS tirzepatide medicines page notes that the doses available in the UK run from 2.5 mg to 15 mg and that your prescriber decides the right level for you. That framing matters: the pen sizes are a toolkit, not a curriculum you must complete at a fixed pace.

What distinguishes each pen size in practice

Every Mounjaro KwikPen, regardless of strength, contains four doses and is used once a week. The physical pen across the range looks similar; the difference is the concentration of tirzepatide inside. You can read more about how the device itself works on our Mounjaro pen guide.

2.5 mg is the universal starting point. 5 mg is the first therapeutic step, where many people begin to notice a meaningful shift in appetite. 7.5 mg sits in the middle of the range and is where some patients remain if the higher doses bring side effects they prefer to avoid. 10 mg and 12.5 mg are intermediate maintenance options, useful when 15 mg proves too much but 7.5 mg feels insufficient. 15 mg is the ceiling and the strength that produced the headline SURMOUNT results, though not everyone needs or tolerates it.

One practical point worth knowing: the pens are not interchangeable by cutting doses in half or injecting twice from a lower-strength pen. Each pen delivers a set amount per click. Switching between sizes is something your prescriber manages, not something you improvise. The Mounjaro injection guide covers technique and site rotation in more detail.

Needles, pen compatibility and what comes in the box

Mounjaro KwikPens do not come with needles included. The pen uses standard 4 mm pen needles, changed with each injection. Many patients are surprised by this the first time a pen arrives. If you want to know more about compatible needle lengths and gauges, the Mounjaro needle size page covers the options used with this pen. Changing the needle before each of the four weekly injections in a pen is standard practice, not optional.

Sharps disposal matters too. Each used needle is a biohazard, a sharps container keeps them safely contained until you can hand them in at a pharmacy. Your local pharmacy can take used sharps free of charge under the NHS scheme.

On the question of cost: pen prices vary by strength and by provider, and the context matters more than the headline number. Our Mounjaro cost and access page sets out what a legitimate private prescription includes and why the price breakdown looks the way it does, particularly after Eli Lilly's UK list price changes in September 2025.

Choosing the right pen size is a prescriber's call, not a consumer decision

The six pen sizes exist on a clinical pathway. A prescriber looks at how much weight you have lost, how well you tolerated the previous dose, and any side effects you reported before deciding whether to move you up, hold you at the current strength, or reduce. Nobody starts at 15 mg.

At nume, a GPhC-registered Independent Prescriber reviews every consultation the same day, the same person reads your answers, not a piece of software. For anyone considering a dose increase, our prescribers check evidence of current treatment and weight progress before any change is made. If you are transferring from another provider, that same review happens. Details of our clinical approach are on the about us page and the clinical oversight is described on our clinical team profile.

If you are not yet on treatment and are wondering whether the licensed pen schedule suits your situation, the right first step is a clinical consultation rather than a packaging comparison. Check your eligibility and start a free consultation at our weight-loss treatments page.